1. Wiechers DO, Johnson EW. Diffuse abnormal electromyographic insertional activity: a preliminary report. Arch Phys Med Rehabil. 1979. 60:419–422.
2. Chow DW, Slipman CW, Ellen M, Lenrow D. "EMG disease" with bulbar muscle involvement: a case report. Arch Phys Med Rehabil. 2002. 83:568–569.
Article
3. Wright KC, Ramsey-Goldman R, Nielsen VK, Nicholas JJ. Syndrome of diffuse abnormal insertional activity: case report and family study. Arch Phys Med Rehabil. 1988. 69:534–536.
4. Mitchell CW, Bertorini TE. Diffusely increased insertional activity: "EMG disease" or asymptomatic myotonia congenita? A report of 2 cases. Arch Phys Med Rehabil. 2007. 88:1212–1213.
Article
5. Wiechers D, Stow R, Johnson EW. Electromyographic insertional activity mechanically provoked in the biceps brachii. Arch Phys Med Rehabil. 1977. 58:573–578.
6. Dumitru D, Martinez CT. Propagated insertional activity: a model of positive sharp wave generation. Muscle Nerve. 2006. 34:457–462.
Article
7. Oh SJ. Clinical Electromyography: Nerve Conduction Studies. 1993. 2nd ed. Baltimore: Williams & Wilkins.
8. Dumitru D, Amato AA, Zwarts MJ. Electrodiagnostic Medicine. 2002. 2nd ed. Philadelphia: Hanley & Belfus;274–278.
9. Fournier E, Viala K, Gervais H, Sternberg D, Arzel-Hézode M, Laforêt P, et al. Cold extends electromyography distinction between ion channel mutations causing myotonia. Ann Neurol. 2006. 60:356–365.
Article
10. Lee SC, Kim HS, Park YE, Choi YC, Park KH, Kim DS. Clinical diversity of SCN4A-mutation-associated skeletal muscle sodium channelopathy. J Clin Neurol. 2009. 5:186–191.
Article
11. Nutter P, Collins K. Diffuse positive waves: case report. Arch Phys Med Rehabil. 1988. 69:295–296.
12. Young NP, Daube JR, Sorenson EJ, Milone M. Absent, unrecognized, and minimal myotonic discharges in myotonic dystrophy type 2. Muscle Nerve. 2010. 41:758–762.
Article
13. Liquori CL, Ricker K, Moseley ML, Jacobsen JF, Kress W, Naylor SL, et al. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science. 2001. 293:864–867.
Article
14. Day JW, Ricker K, Jacobsen JF, Rasmussen LJ, Dick KA, Kress W, et al. Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum. Neurology. 2003. 60:657–664.
15. Merlini L, Sabatelli P, Columbaro M, Bonifazi E, Pisani V, Massa R, et al. Hyper-CK-emia as the sole manifestation of myotonic dystrophy type 2. Muscle Nerve. 2005. 31:764–767.
Article